Sean Stalfort

Sean Stalfort

Director/Board Member at TAYSHA GENE THERAPIES, INC.

Net worth: 8 M $ as of 2024-04-29

53 year
Health Technology
Finance
Commercial Services

Sean Stalfort active positions

CompaniesPositionStartEnd
VERRICA PHARMACEUTICALS INC. Director/Board Member 2015-11-30 -
ACUMEN PHARMACEUTICALS, INC. Director/Board Member 2018-09-30 -
Independent Dir/Board Member 2018-09-30 -
TAYSHA GENE THERAPIES, INC. Director/Board Member 2023-06-20 -
Independent Dir/Board Member 2023-06-20 -
Octagon Partners LLC Corporate Officer/Principal - -
Director/Board Member - -
Novartis Gene Therapies Switzerland GmbH Director/Board Member - -
Vetana Animal Health, Inc. Director/Board Member - -
Baxis Pharmaceuticals, Inc. Director/Board Member - -
Director/Board Member - -
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ - -
░░░░░░░ ░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ - -
░░░ ░░░░░░░ ░░░░░ ░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░ -
░░░░░░░ ░░░░░░░░░░ -
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ - -

Career history of Sean Stalfort

Former positions of Sean Stalfort

CompaniesPositionStartEnd
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░ ░░░░░ ░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ - -
░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ - -
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ - -
░░░ ░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ - -
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ - -
░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ - -
░░░░░░░ ░░░░░░░ ░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ - -
░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ - -

Training of Sean Stalfort

Brown University Undergraduate Degree
University of Massachusetts Undergraduate Degree

Statistics

International

United States 28
Switzerland 2

Operational

Director/Board Member 15
Corporate Officer/Principal 8
Founder 2

Sectoral

Health Technology 12
Finance 7
Commercial Services 3

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies4
VERRICA PHARMACEUTICALS INC.

Health Technology

ACUMEN PHARMACEUTICALS, INC.

Health Technology

CANDEL THERAPEUTICS, INC.

Health Technology

TAYSHA GENE THERAPIES, INC.

Health Technology

Private companies22

Finance

Commercial Services

Ravelin Capital Group LLC

Greenwich Capital Holdings, Inc.

Finance

Finance

CS First Boston Pacific, Inc.

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Finance

Finance

Octagon Partners LLC

Health Technology

Health Technology

Baxis Pharmaceuticals, Inc.

Vetana Animal Health, Inc.

Novartis Gene Therapies Switzerland GmbH

Health Technology

Health Technology

Koch Financial Corp. /Municipal Lending Business/

Finance

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW